We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+15.44%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$17B
AUM Growth
-$1.5B
(-8.1%)
Cap. Flow
-$3.24B
Cap. Flow
% of AUM
-19.02%
Top 10 Holdings %
Top 10 Hldgs %
26.33%
Holding
2,961
New
180
Increased
949
Reduced
1,091
Closed
240
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coeur Mining
CDE
|
+$20.8M |
| 2 |
Atlantic Union Bankshares
AUB
|
+$16.7M |
| 3 |
Lincoln National
LNC
|
+$14.7M |
| 4 |
JBTM
JBT Marel
JBTM
|
+$13.3M |
| 5 |
Yeti Holdings
YETI
|
+$12.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$997M |
| 2 |
Amazon
AMZN
|
+$539M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$276M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$254M |
| 5 |
Bank of America
BAC
|
+$71.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.35% |
| 2 | Financials | 13.45% |
| 3 | Industrials | 10.46% |
| 4 | Healthcare | 10.18% |
| 5 | Communication Services | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Spyre Therapeutics
SYRE
$8.98B
| $448K | ﹤0.01% |
29,918
+6,185
| +26% | +$91.5K |
|
1727
Gorman-Rupp
GRC
$2.15B
| $445K | ﹤0.01% |
12,132
| – | – |
|
1728
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
| $443K | ﹤0.01% |
8,404
| – | – |
|
1729
SoFi Technologies
SOFI
$23.8B
| $443K | ﹤0.01% |
24,348
-2,205
| -8% | -$29.1K |
|
1730
Praxis Precision Medicines
PRAX
$10.8B
| $442K | ﹤0.01% |
10,520
-77
| -0.7% | -$2.93K |
|
1731
Microvast
MVST
$341M
| $440K | ﹤0.01% |
+121,076
| New | +$354K |
|
1732
Marcus & Millichap
MMI
$1.18B
| $438K | ﹤0.01% |
14,278
| – | – |
|
1733
Lifestance Health
LFST
$4.67B
| $437K | ﹤0.01% |
84,562
| – | – |
|
1734
Wave Life Sciences
WVE
$1.02B
| $437K | ﹤0.01% |
67,257
+11,854
| +21% | +$78.3K |
|
1735
Cable One
CABO
$191M
| $436K | ﹤0.01% |
3,210
-182
| -5% | -$34.2K |
|
|
NAGE
1736
Niagen Bioscience
NAGE
$242M
| $434K | ﹤0.01% |
30,126
| – | – |
|
1737
MiMedx Group
MDXG
$624M
| $434K | ﹤0.01% |
70,995
+2,233
| +3% | +$14.9K |
|
1738
Universal Insurance Holdings
UVE
$1.18B
| $433K | ﹤0.01% |
15,608
+1,445
| +10% | +$36.7K |
|
1739
Shoals Technologies Group
SHLS
$1.4B
| $432K | ﹤0.01% |
101,762
+12,637
| +14% | +$54.9K |
|
1740
RUM Group Inc
RUM
$3.74B
| $432K | ﹤0.01% |
+48,100
| New | +$411K |
|
1741
Dream Finders Homes
DFH
$1.31B
| $432K | ﹤0.01% |
17,182
+157
| +0.9% | +$3.53K |
|
|
PRO
1742
DELISTED
PROS Holdings
PRO
| $431K | ﹤0.01% |
27,526
| – | – |
|
1743
REX American Resources
REX
$1.44B
| $431K | ﹤0.01% |
17,678
| – | – |
|
|
AGNT
1744
AGNT Inc
AGNT
$715M
| $430K | ﹤0.01% |
47,215
+4,847
| +11% | +$42.3K |
|
1745
Twilio
TWLO
$37.9B
| $430K | ﹤0.01% |
3,454
-614
| -15% | -$65.3K |
|
1746
Energy Recovery
ERII
$397M
| $429K | ﹤0.01% |
33,598
| – | – |
|
1747
Metropolitan Bank Holding Corp
MCB
$1.17B
| $429K | ﹤0.01% |
6,133
| – | – |
|
|
CFLT
1748
DELISTED
Confluent
CFLT
| $429K | ﹤0.01% |
17,211
+1,986
| +13% | +$44.8K |
|
1749
Corcept Therapeutics
CORT
$12.1B
| $429K | ﹤0.01% |
5,843
-41,520
| -88% | -$3.01M |
|
1750
Esquire Financial Holdings
ESQ
$1.61B
| $429K | ﹤0.01% |
4,529
+494
| +12% | +$42.7K |
|
Similar funds
PCM
HHII
EIM
P
BPA
NAM
MIC
MetLife Investment Management's Q2 2025 Portfolio in Review
As of Q2 2025, MetLife Investment Management held 2,961 positions worth $17B, down 8.1% from $18.5B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
MetLife Investment Management withdrew a net $3.24B in Q2 2025, closing 240 positions and reducing 1,091 holdings. Its most notable exit was Apple, an estimated $997M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.
Against the trend, MetLife Investment Management opened a new position in Amrize Ltd worth $2.51M.
- MetLife Investment Management's largest Q2 2025 buy was Amrize Ltd: 50,407 shares worth $2.51M.
- MetLife Investment Management added most to Coeur Mining in Q2 2025, an estimated $20.8M increase.
- MetLife Investment Management's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $276M.
- MetLife Investment Management fully exited Apple in Q2 2025, selling an estimated $997M.
- MetLife Investment Management's ten largest holdings make up 26% of its $17B portfolio in Q2 2025.
- MetLife Investment Management opened 180 new positions and closed 240 in Q2 2025.
- MetLife Investment Management's portfolio value fell 8.1% quarter-over-quarter to $17B.
Based on MetLife Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.